Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06797960

Ultrasound Guided Intra Articular Injection of Platelet Rich Fibrin Versus Hyaluronic Acid As Means of Pain Relief in Patients with Moderate Degree Knee Osteoarthritis

Randomised controlled trial

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

45 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA I, II.
  • Moderate knee osteoarthritis

Exclusion criteria

  • Neurological patients.
  • Patients with uncontrolled co morbidities

Treatment and study plan

Ultra sound guided Injection of PRF intra articularly

Device

Intra articular injection of PRF

Intra articular injection of HA

Drug

Intra articular injection of HA

Primary outcomes

  1. Pain relief as measured by VAS score

    Time frame: 3 months

Study contacts

Contact information is provided by the study sponsor or research team.

Islam Shaban Shaban

CONTACT

00201008757498

Sponsors and collaborators

Lead sponsor

Fayoum University

Other

Registry information

Official study title

ANALGESIC EFFECT of ULTRASOUND GUIDED INTRA- ARTICULAR INJECTION of PLATELET RICH FIBRIN VERSUS INJECTION of HYALURONIC ACID in PATIENTS with MODERATE KNEE OSTEOARTHRITIS. a RANDOMIZED CONTROLLED STUDY

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jan 29, 2025
Registry last updated
Jan 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.